Inhibition of Interleukin-6 activity by tocilizumab improves arterial stiffness, LV myocardial deformation and endothelial glycocalyx in patients with rheumatoid arthritis.
26 August 2017 (00:00 - 00:00)
Organised by:
About the speaker
National & Kapodistrian University of Athens, Athens (Greece)
4 More presentations in this session
Professor D. Duncker (Rotterdam, NL)
Akap1 modulates endothelial cells function, arterial systolic blood pressure and vascular reactivity
Doctor F. Cattaneo (Naples, IT)
Professor J. Kaski (London, GB)
Access the full session
The Event
ESC Congress 2017
26 August - 30 August 2017
